Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma

Published:2015 Issue:2 Volume:4 Page:115-125
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Siegel Abby B.,El-Khoueiry Anthony B.,Finn Richard S.,Guthrie Katherine A.,Goyal Abhishek,Venook Alan P.,Blanke Charles D.,Verna Elizabeth C.,Dove Lorna,Emond Jean,Kato Tomoaki,Samstein Benjamin,Busuttil Ronald,Remotti Helen,Coffey Amy,Brown Jr Robert S.

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors;Cancers;2024-06-28

2. Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma;Digestive and Liver Disease;2024-06

3. Immunotherapy and Liver Transplantation;Surgical Clinics of North America;2024-02

4. Hepatocellular carcinoma recurrence: Predictors and management;Liver Research;2023-12

5. Growing need of adjuvant therapy and expanded access for liver transplant in hepatocellular carcinoma;Annals of Translational Medicine;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP